FOREPONT CAPITAL LLC
FOREPONT CAPITAL LLC is a Pre-seed, Seed, Series A and Series C+ fund in the US and Europe writing $1M–$10M checks into Healthcare, life-sciences, biotechnology and medical-devices.
- Stages
- Pre-seed, Seed, Series A, Series C+
- Sectors
- Healthcare, life-sciences, biotechnology, medical-devices
- Check size
- $1M–$10M
- Invests in
- US-wide, Europe
- Round role
- Leads rounds
- Actively investing
- Yes
- Founded
- 2017
- Assets under management
- $97.7M
- Website
- forepont.com
Thesis
Their investment strategy centers on early-stage companies translating scientific discoveries into therapeutic and diagnostic products. Forepont invests from pre-seed to growth equity, with a preference for Series A and early-growth rounds, often leading or co-leading investments. Their geographic scope covers North America and Europe, with deal activity split between the U.S. East Coast and Western European hubs like Paris and London. A distinctive feature is their philanthropy-investment hybrid model, funding medical research and then investing in commercial enterprises emerging from these endeavors, granting them privileged deal flow access through relationships with hospitals, universities, and pharmaceutical groups. Investment criteria prioritize scientific and technological advancements, considering medical, human, financial, and ethical implications. As of December 31, 2024, the firm managed approximately $97.7 million in regulatory assets under management. Typical check sizes range from $1 million to $10 million.
Common questions
Does FOREPONT CAPITAL LLC invest at the Pre-seed stage?
Yes. FOREPONT CAPITAL LLC lists Pre-seed, Seed, Series A and Series C+ among the stages it invests in.
What check size does FOREPONT CAPITAL LLC write?
FOREPONT CAPITAL LLC writes $1M–$10M checks.
Where does FOREPONT CAPITAL LLC invest?
FOREPONT CAPITAL LLC invests in the US and Europe.